This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Medical Oncology Group of Australia | |
|---|---|
| Name | Medical Oncology Group of Australia |
| Abbreviation | MOGA |
| Formation | 1970s |
| Type | Professional association |
| Headquarters | Australia |
| Membership | Medical oncologists |
| Leader title | President |
Medical Oncology Group of Australia
The Medical Oncology Group of Australia is a professional association representing medical oncologists in Australia. It operates within the Australian oncology landscape alongside organisations such as Cancer Council Australia, Royal Australasian College of Physicians, Australian Commission on Safety and Quality in Health Care, Peter MacCallum Cancer Centre, and Royal College of Pathologists of Australasia. The Group engages with national and international bodies including World Health Organization, International Agency for Research on Cancer, European Society for Medical Oncology, American Society of Clinical Oncology, and Union for International Cancer Control.
The organisation traces its origins to collaborative meetings among clinicians at institutions such as Royal Prince Alfred Hospital, St Vincent's Hospital, Sydney, and Royal Brisbane and Women's Hospital during the late 20th century, paralleling developments at Memorial Sloan Kettering Cancer Center, MD Anderson Cancer Center, and Peter MacCallum Cancer Centre. Early founders worked alongside leaders from Royal Melbourne Hospital, Royal Adelaide Hospital, and research units at Garvan Institute of Medical Research and Walter and Eliza Hall Institute to formalise standards comparable to those promoted by National Comprehensive Cancer Network, European Organisation for Research and Treatment of Cancer, and Cancer Institute New South Wales. Over ensuing decades the Group interacted with agencies such as Therapeutic Goods Administration and Pharmaceutical Benefits Advisory Committee on drug approval and access issues, reflecting influences from cases like TGA approvals and debates similar to those involving PBS listings.
The Group is governed by an elected executive including a President, Treasurer, and Secretary who liaise with committees on ethics, education, and trials, mirroring governance seen in Royal Australasian College of Surgeons and Australian Medical Association. Committees coordinate with hospital credentialing bodies at Monash Health, Queensland Health, and NSW Health and maintain links with research councils such as the National Health and Medical Research Council. Governance practices reference models used by Australian Cancer Research Foundation, Cancer Australia, and academic governance at University of Melbourne and University of Sydney faculties.
Membership comprises specialist clinicians trained in medical oncology with fellowship or specialist recognition comparable to pathways at Royal Australasian College of Physicians, Australian Medical Council, and accredited training sites including Royal Hobart Hospital and Gold Coast University Hospital. Certification processes align with standards from organisations such as Conjoint Committee for Specialist Recognition and credentialing frameworks used by Australian Health Practitioner Regulation Agency and specialist colleges in New Zealand. Members commonly hold appointments at research and clinical centres including Children's Hospital at Westmead, Adelaide Cancer Centre, and Calvary Mater Newcastle.
The Group develops and endorses clinical guidance that interfaces with guidelines from Cancer Council Australia, Cancer Institute NSW, European Society for Medical Oncology, and American Society of Clinical Oncology. Guidance covers systemic therapy, supportive care, and survivorship aligned with evidence from trials at Peter MacCallum Cancer Centre, Royal Marsden Hospital, and cooperative groups such as National Cancer Institute networks and Australian and New Zealand Urogenital and Prostate Cancer Trials Group. Standards incorporate regulatory frameworks from Therapeutic Goods Administration and reimbursement contexts like Pharmaceutical Benefits Scheme.
The Group supports investigator-initiated trials and collaborates with cooperative groups and institutes such as Australian and New Zealand Trials Group, Cancer Trials Australia, National Health and Medical Research Council, Garvan Institute of Medical Research, Walter and Eliza Hall Institute, Peter MacCallum Cancer Centre, and international partners including European Organisation for Research and Treatment of Cancer and National Cancer Institute. Members participate in trials of targeted therapy, immunotherapy, and precision oncology aligned with research programs at University of Sydney, University of Queensland, Monash University, and biopharmaceutical collaborations resembling activities at CSL Limited and multinational sponsors like Pfizer, Roche, and Bristol Myers Squibb.
The Group organises scientific meetings, workshops, and continuing professional development activities similar to conferences hosted by American Society of Clinical Oncology, European Society for Medical Oncology, and national congresses at venues used by Australian Medical Association and universities including University of Melbourne and University of New South Wales. Educational outreach includes trainee support, mentorship linking to training pathways at Royal Australasian College of Physicians, and collaboration with registrars in training at hospitals such as Royal Perth Hospital and Fiona Stanley Hospital.
The Group advocates on access to medicines, workforce planning, and clinical trial infrastructure, engaging with policy bodies including Department of Health and Aged Care (Australia), Pharmaceutical Benefits Advisory Committee, Therapeutic Goods Administration, Cancer Australia, and state health departments such as NSW Health and Queensland Health. Its policy positions intersect with public debates involving organisations like Cancer Council Australia, consumer groups such as CanCare Advocates, and peak bodies including Australian Clinical Trials Alliance.
Category:Medical associations based in Australia Category:Cancer organizations